Earnings Call Insights: Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Gene Kinney, President and CEO, emphasized Prothena's focus on addressing significant unmet medical needs through its ...
Prothena Corporation ( (PRTA)) has released its Q4 earnings. Here is a breakdown of the information Prothena Corporation presented to its investors. Discover the Best Stocks and Maximize Your ...
Piper Sandler analyst Yasmeen Rahimi raised the firm’s price target on Prothena (PRTA) to $110 from $94 and keeps an Overweight rating on the shares. The firm notes Prothena has multiple key ...
RBC Capital lowered the firm’s price target on Prothena (PRTA) to $20 from $24 and keeps a Sector Perform rating on the shares. The company’s Q4 earnings reflected a pipeline whose timelines ...